Angiotensin II Receptor Blocker‐Associated Angioedema: On the Heels of ACE Inhibitor Angioedema
Authors:
- 1 September 2002
- journal article
- case report
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 22 (9) , 1173-1175
Abstract
Angioedema and cough are known side effects of angiotensin‐converting enzyme (ACE) inhibitors. Angiotensin‐converting enzyme is a potent inhibitor of kinase II, which facilitates the breakdown of bradykinin. An increase in bradykinin levels results in continued prostaglandin E2 synthesis, vasodilation, increased vascular permeability, and increased interstitial fluid. In contrast, the angiotensin II receptor blockers (ARBs) do not increase bradykinin levels. Angioedema as a complication of ACE inhibitor therapy is not widely recognized; this complication is even less recognized with second‐line ARBs. We report angioedema associated with losartan (an ARB) in a patient who had experienced angioedema secondary to enalapril (an ACE inhibitor). Almost half of patients with ARB‐associated angioedema also had developed angioedema while receiving ACE inhibitor therapy. Clinicians should exercise caution when using ARBs in patients with a history of angioedema secondary to ACE inhibitors.Keywords
This publication has 24 references indexed in Scilit:
- ACE Inhibitor???Induced AngioedemaDrug Safety, 1998
- Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitorArchives of Dermatology, 1997
- Recurrent angiotensin-converting enzyme inhibitor--associated angioedemaJAMA, 1997
- Angiotensin‐converting enzyme inhibitor‐induced angioedema: late onset, irregular course, and potential role of triggersAllergy, 1997
- Angioedema of ACE inhibitorsAllergy, 1997
- Angiotensin II receptor inhibition. A new therapeutic principleArchives of internal medicine (1960), 1996
- Accupril- and Cozaar-induced angioedema in the same patientJournal of Allergy and Clinical Immunology, 1996
- Angioedema Induced by the Angiotensin II Blocker LosartanNew England Journal of Medicine, 1995
- Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertensionThe American Journal of Cardiology, 1995
- Kinin- and Non-Kinin-Mediated Interactions of Converting Enzyme Inhibitors with Vasoactive HormonesJournal of Cardiovascular Pharmacology, 1990